# Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function

> **NCT01438970** · PHASE2 · UNKNOWN · sponsor: **Sequana Medical N.V.** · enrollment: 12 (estimated)

## Conditions studied

- Cirrhosis, Liver
- Refractory Ascites

## Interventions

- **DEVICE:** ALFApump system

## Key facts

- **NCT ID:** NCT01438970
- **Lead sponsor:** Sequana Medical N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438970, "Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01438970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*